You are here: All Products > Dizal’s JAK1 Inhibitor NDA Accepted for China Review as PTCL Therapy
Dizal’s JAK1 Inhibitor NDA Accepted for China Review as PTCL Therapy
You are here: All Products > Dizal’s JAK1 Inhibitor NDA Accepted for China Review as PTCL Therapy